Results 251 to 260 of about 552,068 (289)
Single-cell transcriptomics identifies FOSL1-regulated IGFBP3+ melanoma subtype as a neuro-immunoregulatory signaling hub facilitating tumor progression. [PDF]
Ge W +6 more
europepmc +1 more source
The chromatin guardian ATRX is a strong prognostic biomarker in melanoma. [PDF]
Frei CA +9 more
europepmc +1 more source
Nevus-Associated and De Novo Melanoma: A Cross-Sectional Study on Prognostic Differences. [PDF]
Dika E +11 more
europepmc +1 more source
Lymphatic Complications in Patients Undergoing Melanoma Surgery in Peru. [PDF]
De La Cruz Ku G +10 more
europepmc +1 more source
Targeted therapies and PARPi therapy response following ICI therapy failure in advanced melanoma: a case series. [PDF]
Nassief G +4 more
europepmc +1 more source
Correction for AbuHammad et al., Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma. [PDF]
europepmc +1 more source

